Under the "4 + 7" storm, 100 kinds of commonly used drugs in retail pharmacies will be reduced in price

[industry trends of pharmaceutical network] recently, the medical insurance bureau of Xianning City, Hubei Province issued the proposal on the price reduction of 100 commonly used drugs in the designated retail drugstores of medical insurance in Xianning City, which will make a centralized proposal on the price reduction of 100 commonly used drugs in the designated drugstores of medical insurance in Xianning City It is reported that these 100 commonly used drugs are mainly used to reduce blood lipid, blood pressure, diabetes and other common chronic diseases, including 23 drugs for cardiovascular system, 6 drugs for endocrine hormone, 6 drugs for digestive system, 3 drugs for hepatobiliary system, 3 drugs for nervous system and 2 drugs for facial features Among the 100 commonly used drugs, there are some large varieties, such as metformin, acarbose, entecavir, atorvastatin, nifedipine, irbesartan, etc According to industry news, the price cut was 46.67% higher and 6.01% lower on average It can be seen that with the price reduction of these 100 commonly used drugs, it is conducive to reducing the burden of drug use for patients It is not difficult to think of the impact of "4 + 7" volume purchase when analyzing the reasons of drug price reduction in retail drugstores After the national implementation of "4 + 7" urban centralized purchase, the price of hospital drugs has been greatly reduced Compared with the low purchase price of the same kind of drugs in 2017, the average price of 25 selected drugs has dropped by 52%, with a high drop of 96% The original price advantage of drugstores is no longer obvious under the background of the change of pharmaceutical market pattern With the implementation of the volume purchase policy, many local pharmacies have simultaneously lowered the price of the winning varieties, and some pharmacies, although not synchronized, have actively adjusted the price or selected off the shelf processing Because the profit of drugs in drugstores comes from the price difference of drugs Under the influence of volume purchase, many retail pharmacies are less likely to win the bidding For example, after Xi'an city implemented "purchasing with quantity", it is difficult for drugstores to find 25 selected drugs, occasionally one or two, and the price has not declined The staff of a drugstore said that atorvastatin calcium sold for 46 yuan Since the price was reduced in the hospital, no one has come to the drugstore to buy the drug Because the purchase price of the drug store is still the original high price For example, in 9 chain drugstores in Dongcheng District, Chaoyang District and Fengtai District of Beijing, the price of some drugs is 7-8 times higher than that of hospitals Some drugstore staff said that the drugstore is based on the sales volume to choose the purchase "The drugs with high brand have more customers We also purchase according to the surrounding customers Although there are some drugs in total stock, we won't buy them, mainly because the cost is too high In addition, if we can't sell them, we need to compensate ourselves after the expiry date It's cheaper to choose hospital drugs Everyone goes to the hospital to buy them It's hard for the drugstore to live in the future " In general, after various dealers increase the price, the sales price of drugstores is significantly higher than that of hospitals, while volume purchase makes the price of drugs in hospitals lower, and the number of customers in drugstores continues to decrease So, how can drugstores find a new way out in the context of the current survival test?
In fact, under the influence of "4 + 7" volume procurement, many chain drugstores in pilot cities have taken a series of contingency measures, such as "gradually reducing or removing the" 4 + 7 "winning products", "temporarily separating hospital prices by means of large package specifications", "focusing on the development of self pricing varieties", etc., which may play a role in maintaining the profits of drugstores in the short term, But not for long It can be seen that the days of making money in the pharmaceutical retail industry have passed Some industry analysts believe that in the shuffle of the retail industry, only the return to pharmaceutical care is the king On the one hand, retail pharmacies need to return to the essence of value and improve the viscosity of high-value consumers by providing differentiated services with community medical institutions On the other hand, retail pharmacies need to pay attention to the adjustment of category structure and balance passenger flow and profit.